Zusammenfassung
Endotoxine sind integraler Bestandteil der äußeren Membran gramnegativer Bakterien wie Enterobakteriaceae, Neisserien und Chlamydien. Sie sind bei zahlreichen physiologischen Membranfunktionen beteiligt und sind essentiell für das Wachstum von Bakterien und deren Überleben. Endotoxine repräsentieren die hitzestabilen O-Antigene von Bakterien und definieren somit die Vielfalt der unterschiedlichen Serotypen. Schließlich zeigen Endotoxine ein großes Spektrum biologischer Aktivitäten nach der Injektion in Tieren und in In-vitro-Modellen [28].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alpert G, Baldwin G, Thompson C et al. (1992) Limulus antipolysaccharide factor protects rabbits from meningococcal endotoxin shock. Infect Dis 165: 494–500
Bazil V, Strominger, JL (1991) Shedding as a mechanism of down-modulation of CD 14 on stimulated human monocytes. J Immunol 147: 1567–1574
Desch CE, O’Hara P, Harlan J (1989) Anti-lipopolysaccharide factor from T. tridentatus inhibits lipopolysaccharide activation of cultured human endothelial cells. Infect Immun 57: 1612–1614
DiPadova FE, Brade H, Barclay R et al. (1993) A broadly cross-protective monoclonal antibody binding to E. coli and Salmonella lipopolysaccharide. Infect Immun 61: 3863–3872
Fletcher M, McKenna TM, Quance JL, Wainwright NR, Williams TJ (1993) Lipopolysaccharide detoxification by endotoxin neutralizing protein. J Surg Res 55: 147–154
Fischer JC, Marra MN, Palardy JE, Marchbanks CR, Scott R, Opal SM (1994) Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: A placebo-controlled study. Crit Care Med 22: 553–558
Garcia C, Thompson C, Hammer B et al. (1994) Efficacy of a recombinant endotoxin neutralizing protein in rabbits with Escherichia coli sepsis. Circ Shock 42: 104–110
Garcia C, Saladino R, Thompson C et al. (1994) Effect of recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits. Crit Care Med 22: 1211–1218
Gazzano-Santoro H, Parent JB, Grinna L et al. (1992) High affinity binding of the bactericidal/permeability increasing protein and a recombinant amino terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun 60: 4754–4761
Gazzano-Santoro H, Meszaros K, Birr C et al. (1994) Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and Gramnegative bacteria. Infect Immun 62: 1184–1191
Grunwald U, Krüger C, Schutt C (1993) Endotoxin-neutralizing capacity of soluble CD 14 is a highly conserved specific function. Circulatory Shock 39: 220–225
Hoess A, Watson S, Siber GR, Liddington R (1993) Crystal structure of an endotoxin-neutralizing protein from horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. EMBO J 12: 3351–3356
Johnson KJ, Ward P, Goralnick BS, Osborn MJ (1977) Isolation from human serum of an inactivator of bacterial lipopolysaccharide. Am J Pathol 88: 559–574
Krüger C, Schutt C, Obertacke U et al. (1991) Serum CD 14 levels in polytraumatized and severely burned patients. Clin Exp Immunol 85: 297–301
Kuppermann N, Nelson D, Saladino R et al. (1994) A comparison of a recombinant endotoxin neutralizing protein with a human monoclonal antibody to endotoxin for the treatment of E. coli sepsis in rats. J Infect Dis 170: 630–635
Loppnow H, Libby P (1989) Adult human vascular endothelial cells express the IL-6 gene differentially in response to LPS or IL-1. Cell Immunol 122: 493–503
Loppnow H, Libby P (1992) Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways. Exp Cell Res 198: 283–290
Loppnow H, Rietschel ET, Brade H et al. (1993) Lipid A precursor la (compound 406) and Rhodobacter capsulatus lipopolysaccharide: potent endotoxin antagonists in the human system in vitro. In: Levin J, Alving CR, Munford RS, Stutz PL (eds) Bacterial endotoxin: Recognition and effector machanisms. Elsevier, New York, pp 337–348
Marra MN, Wilde CG, Snable JL et al. (1990) Bactericidal/permeability-increasing protein has endotoxin neutralizing activity. J Immunol 144: 662–666
Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW (1992) The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxins. J Immunol 148: 532–537
Marra MN, Thornton MB, Snable JL, Wilde CG, Scott RW (1994) Endotoxin-binding and-neutralizing properties of recombinant bactericidal/permeability increasing protein and monoclonal antibodies HA-1A and E5. Crit Care Med 22: 559–565
Morita TS, Ohtsubo T, Nakamura T et al. (1985) Isolation and biological activities of Limulus anticoagulant (anti-lipopolysaccharide factor) which interacts with lipo-polysaccharide (LPS). J Biochem 97: 1611–1620
Muta T, Miyata T, Tokunaga F, Nakamura T, Iwanaga S (1987) Primary structure of anti-lipopolysaccharide factor from American horseshoe crab, Limulus polyphemus. J Biochem 101: 1321–1330
Nathan CF (1987) Secretory products of macrophages. J Clin Invest 79: 319–324
Ooi CE, Weiss J, Doerfler ME, Eisbach P (1991) Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55–60 kD bactericidal/permeability-increasing protein of human neutrophils. J Exp Med 174: 649–655
Pugin J, Schürer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS (1993) Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD 14. Proc Natl Acad Sei USA 90:2744–2748
Rietschel ET, Brade H (1992) Bacterial endotoxins. Sei Am 267: 54–61
Rietschel ET, Kirikae T, Feist W et al. (1991) Molecular aspects of the chemistry and biology of endotoxin. In: Sies H, Flohe L, Zimmer G (eds) 1991. Molecular aspects of inflammation. Springer, Berlin Heidelberg New York Tokyo, pp 207–231
Saladino R, Garcia CT, Thompson C et al. (1991) Assessment of intravenous endotoxin neutralizing protein in a rabbit model. Pediatr Res 29: 33A
Schletter J, Brade H, Krüger C, Loppnow H, Rietschel ET, Flad HD, Ulmer AJ (1994) Binding of lipopolysaccharide to an 80 KDa membrane protein of human cells is mediated by serum factors. Immunobiol 191: 273
Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ (1990) Structur and function of lipopolysaccharide binding protein. Science 249: 1429–1431
Schumann RR, Lamping N, Kirschning C, Knopf HP, Hoess A, Herrmann F (1994) Lipopolysaccharide binding protien: Its role and therapeutic potential in inflammation and sepsis. Biochem Soc Transact 22: 80–83
Schumann RR, Rietschel ET, Loppnow H (in press) The role of CD14 and lipopolysaccharide binding protein [LBP] in the activation of different cell types by endotoxin. Med Mikrobiol Immunol
Schutt C, Schilling T, Krüger C (1991) sCD14 prevents endotoxin induced oxidative burst response of human monocytes. Allerg Immunol 37: 159–164
Schutt C, Schilling T, Grunwald U, Schönfeld W, Krüger C (1992) Endotoxinneutraliz-ing capacity of soluble CD14. Res Immunol 143: 71–78
Seydel U, Brandenburg K, Rietschel ET (1994) A case for an endotoxic conformation. In: Levin J et al. (eds) Bacterial endotoxins: Basic science to anti-sepsis strategies. Wiley/Liss, New York, pp 17–30
Tanaka S, Nakamura T, Morita T, Iwanaga S (1982) Limulus anti-lipopolysaccharide factor: An anticoagulant which inhibits the endotoxinmediated activation of limulus coagulation system. Biochem Biophys Res Commun 105: 717–723
Theofan G, Horwitz AH, Williams ER, et al. (1994) An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD 14-stimulatory activity. J Immunol 152: 3623–3629
Tobias PS, Mathison JC, Ulevitch RJ (1988) A family of lipopolysaccharide binding protiens involved in responses to Gram-negative sepsis. J Biol Chem 263: 13479–13481
Wainwright NR, Müller RJ, Paus E et al. (1990) Endotoxin binding and neutralizing activity by a protein from Limulus polyphemus. In: Novotny A (ed) Cellular and molecular aspects of endotoxin reaction. Elsevier, New York, pp 315–325
Warren HS, Glennon ML, Wainwright N et al. (1992) Binding and neutralization of endotoxin by limulus antilipopolysaccharide factor. Infect Immun 60: 2506–2513
Weinstein SL, Gold MR, DeFranco AL (1991) Bacterial lipopolysaccharide stimulation protein tyrosine phosporylation in macrophages. Proc Natl Acad Sei USA 88: 4148–4152
Weiss J, Eisbach P, Olsson I et al. (1978) Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphnu-clear leukocytes. J Biol Chem 253: 2664–2672
Würfel M, Kunitake ST, Lichenstein H, Kane JP, Wright SD (1994) Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 180: 1025–1035
Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison LC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding proteins. Science 249: 1431–1433
Zähringer U, Lindner B, Rietschel ET (1994) Molecular structure of Lipid A, the endotoxic center of bacterial lipopolysaccharides. Adv Carbohyd Chem Biochem 50:211–276
Ziegler-Heitbrock HWL, Ulevitch RJ (1993) CD14: Cell surface receptor and differentiation marker. Immunol Today 14: 121–125
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zabel, P. (1996). Endotoxinbindende Proteine. In: Schuster, HP. (eds) Intensivtherapie bei Sepsis und Multiorganversagen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07958-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-662-07958-4_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-07959-1
Online ISBN: 978-3-662-07958-4
eBook Packages: Springer Book Archive